These findings indicate that ICA may improve synaptic plasticity through the BDNF/TrkB/Akt pathway and provide further evidence for its clinical application to improve learning and memory in patients with Alzheimer's disease. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.